Development of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin
Recruiting
Observational Study
Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 70 (estimated)
- Sponsor
- Seyoung Shin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To collect large-scale, high-quality clinical data, daily activity and movement patterns, and genomic information from stroke patients spanning the subacute to chronic stages. This study aims to establish the foundation for personalized precision medicine in stroke care and to develop a visual and digital transformation of patient medical information in the era of digital healthcare.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 20 years or older with a confirmed diagnosis of stroke.
* Within 1 month after stroke onset.
* Patients scoring between 0 and 3 points on the Functional Ambulatory Category (FAC) test.
* Patients or their legally authorized representatives who have fully understood…
Contacts